InvestorAndreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley, founded in 2009. The firm invests across various sectors, supporting companies from early-stage startups to growth-stage firms.
Curie.Bio
Curie.Bio is a seed-stage venture capital firm and therapeutics accelerator based in Boston, MA, focusing on empowering biotech founders. They provide capital and operational support to help early-stage therapeutics companies advance from concept to clinical trials.
Online destinations
Find Curie.Bio online
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Official links
Pages the organization runs itself.
Overview
Curie.Bio is a venture capital firm founded in 2022 to assist founders in discovering and developing new medicines. Based in Cambridge/Boston, MA, the firm supports early-stage therapeutics companies by providing seed capital, expert drug discovery support, and operational services. Curie.Bio invests in companies at various stages, from concept to clinical trials, typically providing between $5 million and $15 million through their Seed Fund. They have contributed to the development of over 100 drugs currently in clinical trials and have been involved in the approval of 44 medicines. Their model combines investment with drug discovery copiloting, offering operational support and access to a network of experts to help founders efficiently develop their drug candidates.
Focus
Curie.Bio invests in companies at various stages, from concept-stage to clinical trials, across any modality and therapeutic area. They typically invest between $5 million and $15 million through their Seed Fund to help advance therapies through preclinical milestones, with further funding available through their Breakout Fund for clinical trials.
Support
Curie.Bio offers a unique model that combines investment with drug discovery copiloting. They provide operational support, project management, and access to a network of experts and resources, enabling founders to develop their drug candidates efficiently and effectively.
Questions
What stages does Curie.Bio invest in?
Curie.Bio invests in companies at various stages, including pre-seed, seed, Series A, Series B, and Series C. They focus on early-stage therapeutics companies.
What is the typical check size for investments?
The firm typically invests between $5 million and $15 million, with average check sizes ranging from $7 million to $12 million per company.
How can founders pitch to Curie.Bio?
Founders can submit their proposals through the Curie.Bio contact page. They encourage interested parties to share their proposals for potential funding or collaboration opportunities.
What makes Curie.Bio different from other venture capital firms?
Curie.Bio combines investment with drug discovery copiloting, providing operational support and access to a network of experts. This model allows founders to focus on scientific development rather than infrastructure.
What is the acceptance rate for proposals?
Curie.Bio has a highly selective investment strategy, with a sub-1% acceptance rate for new proposals, indicating a rigorous evaluation process for potential investments.
What types of companies does Curie.Bio prefer to invest in?
The firm focuses on biotech and healthcare companies that are developing therapeutics across various modalities and therapeutic areas. They seek scientific founders with differentiated therapeutic modalities.
Check your startup’s fit
Check your startup’s fit with Curie.BioSimilar investors
Organizations that do similar work to Curie.Bio.
Investor
InvestorSequoia Capital is a venture capital firm based in Silicon Valley, established in 1972. It invests in technology companies at various stages, focusing on long-term partnerships with founders.
InvestorBessemer Venture Partners is a venture capital firm based in Redwood City, California, with additional offices in major cities across the U.S. and internationally. The firm invests in a wide range of sectors, supporting entrepreneurs from early-stage startups to growth-oriented businesses.
InvestorKhosla Ventures is a venture capital firm based in Menlo Park, California, focusing on early-stage investments in technology-driven companies across various sectors, including fintech, healthcare, and sustainability.
Superscout Pro
Find faster. Show up verified. Keep your deals private.
$99a year, or $12 a month
Get Pro- Search that narrowsInvestors, programs, accelerators, incubators and studios, by stage, sector and place.
- A verified profileThe people you reach know you are who you say you are.
- A private deal vaultThe startups you are watching, with your notes and your reasons. Nobody else's eyes.
Is this page right?Reviewed · How the research works